ANTI-HUMAN GLOBULIN (COOMBS) - ANVISA Registration 80020690457

Access comprehensive regulatory information for ANTI-HUMAN GLOBULIN (COOMBS) in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 80020690457 and manufactured by BIO-RAD LABORATORIOS BRASIL LTDA.. The registration is held by BIO-RAD LABORATORIOS BRASIL LTDA with validity until Jun 14, 2031.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 companies making the same product including DIAMED GMBH, ORTHO CLINICAL DIAGNOSTICS, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.